Transition to adulthood for young adults with severe haemophilia

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study follows young adults aged 20-29 with severe haemophilia who previously participated in the TRANSHEMO project. It aims to describe the transition from adolescence to adult care and how it affects health management and quality of life. Data are collected through questionnaires to understand autonomy in health, adherence to follow-up, and overall well-being. Participants are drawn from FranceCoag registry and are recruited at multiple French centers. The study is led by Assistance Publique Hopitaux de Marseille with sites in La Réunion, Annecy, and Bordeaux.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Young adults who participated in the TRANSHEMO project during adolescence and who are currently aged 20-29 years;
* Young adults with severe haemophilia (haemophilia A or B);
* Young adults registered in the FranceCoag registry;
* Young adults who have received the participant information sheet for the TRANSHEMO 2 project;
* Young adults who did not object to participation in the present study.

Exclusion Criteria:

* patients with comprehension difficulties;
* patients who are unable to read and/or write;
* patients who express opposition to participation in this study.

Where it's running

• CH Annecy - St Julien
  Annecy, France Recruiting
• CHU La Reunion
  Saint-Denis, La Réunion, France Not yet recruiting
• Chu de Bordeaux
  Bordeaux, France Not yet recruiting
• Chu de Caen
  Caen, France Not yet recruiting
• Centre hospitalier Métropole Savoie
  Chambéry, France Not yet recruiting
• CHU Clermont-Ferrand
  Clermont-Ferrand, France Not yet recruiting

Study contacts

• Study coordinator: Noémie Resseguier, MD
• Email: noemie.resseguier@univ-amu.fr
• Phone: 0033491324272

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Is synovial proliferation in haemophilia joints active or inactive?

  This project will test whether ultrasound, MRI and elastography can tell if subclinical synovial proliferation in people with severe haemophilia is currently active so clinicians can treat earlier.

  Recruiting UMC Utrecht · Utrecht · NCT06809972

• Investigating heart disease in people with haemophilia

  This study is trying to see how having haemophilia affects the risk of heart disease in men aged 45 and older by using advanced heart imaging techniques.

  Recruiting Oxford University Hospitals NHS Trust · Oxford, Oxfordshire · NCT06706206

• Denecimig (Mim8) for adults with acquired Haemophilia A

  This study tests whether denecimig can be safe and helpful for adults newly diagnosed with acquired Haemophilia A.

  Recruiting Phase 3 Novo Nordisk A/S · Iowa City, Iowa and 82 other locations · NCT07830732

• Surgical Use of Efanoctocog alfa in Hemophilia A Patients

  This observational study looks at how efanesoctocog alfa (Altuvoct) is used around surgery in people with hemophilia A to see if it helps control bleeding.

  Recruiting Hospices Civils de Lyon · Bron · NCT07723560

• SCT800 for preventing and treating bleeds in previously untreated severe hemophilia A patients

  This test tries SCT800, a recombinant factor VIII, as regular prevention and to treat bleeds in male patients with severe hemophilia A who haven't had prior factor VIII treatment.

  Recruiting Phase 3 Sinocelltech Ltd. · Beijing, Beijing Municipality · NCT07437404

• Different doses of Inno8 for adults with haemophilia A.

  This trial will test different doses of the experimental medicine Inno8 in adults with haemophilia A to see if it is safe and how the body handles it.

  Recruiting at 25 sites Phase 1 Novo Nordisk A/S · Aurora, Colorado and 32 other locations · NCT07220564

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.